Chemoinformaics analysis of 4,5-DIETHYLOCTANE
| Molecular Weight | 170.34 | nRot | 7 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 0 |
| Exact Molecular Weight | 170.203 | nRing | 0 |
| Solubility: LogS | -5.792 | nHRing | 0 |
| Solubility: LogP | 5.741 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 37.3766 |
| nHD | 0 | BPOL | 26.0834 |
| QED | 0.522 |
| Synth | 3.141 |
| Natural Product Likeliness | 0.448 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.032 |
| Pgp-sub | 0.004 |
| HIA | 0.003 |
| CACO-2 | -4.297 |
| MDCK | 0.0000128 |
| BBB | 0.453 |
| PPB | 0.975199 |
| VDSS | 2.855 |
| FU | 0.0197371 |
| CYP1A2-inh | 0.779 |
| CYP1A2-sub | 0.876 |
| CYP2c19-inh | 0.495 |
| CYP2c19-sub | 0.907 |
| CYP2c9-inh | 0.674 |
| CYP2c9-sub | 0.751 |
| CYP2d6-inh | 0.148 |
| CYP2d6-sub | 0.309 |
| CYP3a4-inh | 0.535 |
| CYP3a4-sub | 0.261 |
| CL | 7.991 |
| T12 | 0.178 |
| hERG | 0.065 |
| Ames | 0.003 |
| ROA | 0.063 |
| SkinSen | 0.281 |
| Carcinogencity | 0.039 |
| EI | 0.964 |
| Respiratory | 0.159 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.574319 |